Overview

A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke

Status:
Terminated
Trial end date:
2001-07-01
Target enrollment:
Participant gender:
Summary
The aim of this study was to confirm the efficacy of piracetam after 12 weeks of treatment on the aphasic status of subjects suffering from aphasia after acute ischemic middle cerebral artery stroke and having received their medication within 7 h post-stroke onset.
Phase:
Phase 4
Details
Lead Sponsor:
UCB S.A. - Pharma Sector
Treatments:
Piracetam